StockData
Innospec Inc. logo

Innospec Inc. (IOSP) stock

IOSPNasdaqChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3015% below fair value
$78.86+0.85 (+1.09%)

Close on Nov 18, 2026Market cap $1.94BP/E –Yield 2.17%

Innospec operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Innospec's operating income for the twelve months ending Jun 30, 2026 was $128.90M, down 21.2% year over year. For fiscal 2025 it was $129.50M, down 27.2% from the year before. Over ten years it grew -1.9% a year on average. The highest annual figure on record is $187.30M in fiscal 2022.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$129.50M-27.2%
FY2024Dec 31, 2024$177.90M+10.1%
FY2023Dec 31, 2023$161.60M-13.7%
FY2022Dec 31, 2022$187.30M+41.8%
FY2021Dec 31, 2021$132.10M+292.0%
FY2020Dec 31, 2020$33.70M-77.5%
FY2019Dec 31, 2019$149.90M+12.3%
FY2018Dec 31, 2018$133.50M+6.8%
FY2017Dec 31, 2017$125.00M+27.3%
FY2016Dec 31, 2016$98.20M-37.2%
FY2015Dec 31, 2015$156.30M+38.9%
FY2014Dec 31, 2014$112.50M+24.2%
FY2013Dec 31, 2013$90.60M-6.1%
FY2012Dec 31, 2012$96.50M+104.4%
FY2011Dec 31, 2011$47.20M-34.6%
FY2010Dec 31, 2010$72.20M+248.8%
FY2009Dec 31, 2009$20.70M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$39.70M+15.7%
Q1 FY2026Mar 31, 2026$36.50M-14.1%
Q4 FY2025Dec 31, 2025$46.80M+13.9%
Q3 FY2025Sep 30, 2025$5.90M-87.1%
Q2 FY2025Jun 30, 2025$34.30M-15.7%
Q1 FY2025Mar 31, 2025$42.50M-15.8%
Q4 FY2024Dec 31, 2024$41.10M-7.6%
Q3 FY2024Sep 30, 2024$45.60M+8.8%
Q2 FY2024Jun 30, 2024$40.70M+19.0%
Q1 FY2024Mar 31, 2024$50.50M+23.2%
Q4 FY2023Dec 31, 2023$44.50M-4.5%
Q3 FY2023Sep 30, 2023$41.90M-16.4%
Q2 FY2023Jun 30, 2023$34.20M-26.1%
Q1 FY2023Mar 31, 2023$41.00M-7.4%
Q4 FY2022Dec 31, 2022$46.60M+31.3%
Q3 FY2022Sep 30, 2022$50.10M+59.6%
Q2 FY2022Jun 30, 2022$46.30M+25.1%
Q1 FY2022Mar 31, 2022$44.30M+57.1%
Q4 FY2021Dec 31, 2021$35.50M+20.7%
Q3 FY2021Sep 30, 2021$31.40M+86.9%
Q2 FY2021Jun 30, 2021$37.00M–
Q1 FY2021Mar 31, 2021$28.20M-31.1%
Q4 FY2020Dec 31, 2020$29.40M-32.9%
Q3 FY2020Sep 30, 2020$16.80M-56.0%
Q2 FY2020Jun 30, 2020-$53.40M-268.5%
Q1 FY2020Mar 31, 2020$40.90M+13.0%
Q4 FY2019Dec 31, 2019$43.80M+2.1%
Q3 FY2019Sep 30, 2019$38.20M+14.4%
Q2 FY2019Jun 30, 2019$31.70M+12.0%
Q1 FY2019Mar 31, 2019$36.20M+25.3%
Q4 FY2018Dec 31, 2018$42.90M+15.3%
Q3 FY2018Sep 30, 2018$33.40M+15.2%
Q2 FY2018Jun 30, 2018$28.30M-15.5%
Q1 FY2018Mar 31, 2018$28.90M+14.2%
Q4 FY2017Dec 31, 2017$37.20M+48.2%
Q3 FY2017Sep 30, 2017$29.00M+53.4%
Q2 FY2017Jun 30, 2017$33.50M–
Q1 FY2017Mar 31, 2017$25.30M–
Q4 FY2016Dec 31, 2016$25.10M–
Q3 FY2016Sep 30, 2016$18.90M–

More Innospec figures

See a number that looks wrong?